Cardiovascular Research·11 AugDual inhibition of SGLT 1 and 2 by sotagliflozin alleviates intracellular sodium overload and improves cardiometabolic remodelling in uraemic cardiomyopathyExperiments in animalsInterventionsPaper
ADA Scientific Sessions 2026 Abstract·5 JunTirzepatide Enhances Metabolic Outcomes in People with Type 1 Diabetes and Overweight/Obesity: A Retrospective Cohort Study at Sydney's Royal North Shore HospitalStudy in peopleInterventionsPaper
ADA Scientific Sessions 2025 Abstract·13 JunGlucometabolic Outcomes in Patients with Concurrent Overweight/Obesity and Type 1 Diabetes following Prolonged Glucagon-Like Peptide 1 Receptor Agonist Treatment—A Systematic Review and Meta-analysisReviewInterventionsPaper